Search research articles
Contact Us
Filters
Showing results (221-230 of 232) with videos related to
Page
of 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2018
FDA Approval Summary: Pertuzumab for Adjuvant Treatment of HER2-Positive Early Breast Cancer
Lynn J Howie, Nancy S Scher, Laleh Amiri-Kordestani, et al.
Head & Neck
|
June 22, 2023
Comparative impact of grade on mortality across salivary cancers: A novel, unifying staging system
Allen S Ho, Michael Luu, Bonnie L Balzer, et al.
Oral Oncology
|
June 23, 2024
Patient perceptions underlying ctDNA molecular surveillance for HPV(+) oropharyngeal squamous cell carcinoma
Amanda J Bastien, Jewel Ng, Iris Cong, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society
|
January 3, 2025
The American Clinical Neurophysiology Society Guideline on Indications for Continuous Electroencephalography Monitoring in Neonates
Courtney J Wusthoff, Adam L Numis, Ronit M Pressler, et al.
Pediatric Research
|
January 7, 2026
Neonatal neurocritical care considerations for prenatally identified neurological disorders
Dawn Gano, James P Boardman, Sonika Agarwal, et al.
Blood
|
November 11, 2006
End points to establish the efficacy of new agents in the treatment of acute leukemia
Frederick R Appelbaum, Daniel Rosenblum, Robert J Arceci, et al.
Head & Neck
|
July 30, 2024
Baseline weight recovery and mortality risk in head and neck cancer
Amanda J Bastien, Luv Amin, Missael Vasquez, et al.
Frontiers in Neurology
|
January 23, 2026
An interdisciplinary fetal neonatal neurology collaborative promotes integrative life-course brain health
Mark S Scher, Harris Eyre, Steven Donn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2013
First FDA approval of dual anti-HER2 regimen: pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer
Gideon M Blumenthal, Nancy S Scher, Patricia Cortazar, et al.
Science Advances
|
July 3, 2026
Single-cell transcriptomic analysis reveals tumor-immune determinants of lymph node colonization and progression in thyroid cancer
Anthony T Nguyen, Jolene Viramontes, Isaiah Vazquez, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 232) with videos related to
Sort By:
Page
of 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2018
FDA Approval Summary: Pertuzumab for Adjuvant Treatment of HER2-Positive Early Breast Cancer
Lynn J Howie, Nancy S Scher, Laleh Amiri-Kordestani, et al.
Head & Neck
|
June 22, 2023
Comparative impact of grade on mortality across salivary cancers: A novel, unifying staging system
Allen S Ho, Michael Luu, Bonnie L Balzer, et al.
Oral Oncology
|
June 23, 2024
Patient perceptions underlying ctDNA molecular surveillance for HPV(+) oropharyngeal squamous cell carcinoma
Amanda J Bastien, Jewel Ng, Iris Cong, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society
|
January 3, 2025
The American Clinical Neurophysiology Society Guideline on Indications for Continuous Electroencephalography Monitoring in Neonates
Courtney J Wusthoff, Adam L Numis, Ronit M Pressler, et al.
Pediatric Research
|
January 7, 2026
Neonatal neurocritical care considerations for prenatally identified neurological disorders
Dawn Gano, James P Boardman, Sonika Agarwal, et al.
Blood
|
November 11, 2006
End points to establish the efficacy of new agents in the treatment of acute leukemia
Frederick R Appelbaum, Daniel Rosenblum, Robert J Arceci, et al.
Head & Neck
|
July 30, 2024
Baseline weight recovery and mortality risk in head and neck cancer
Amanda J Bastien, Luv Amin, Missael Vasquez, et al.
Frontiers in Neurology
|
January 23, 2026
An interdisciplinary fetal neonatal neurology collaborative promotes integrative life-course brain health
Mark S Scher, Harris Eyre, Steven Donn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2013
First FDA approval of dual anti-HER2 regimen: pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer
Gideon M Blumenthal, Nancy S Scher, Patricia Cortazar, et al.
Science Advances
|
July 3, 2026
Single-cell transcriptomic analysis reveals tumor-immune determinants of lymph node colonization and progression in thyroid cancer
Anthony T Nguyen, Jolene Viramontes, Isaiah Vazquez, et al.
Page
of 24